Background: An increase in the number of cardiac implantable electronic device (CIED) implantations is associated with a higher frequency of electrotherapy complications.
INTRODUCTION
The rise in the number of cardiac implantable electronic device (CIED) implantations: pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronisation therapy (CRT) devices, resulting from broader indications for implantation and a change in patient profile, is associated with an increased incidence of complications of electrotherapy [1] [2] [3] [4] [5] . Particularly important are the late complications, appearing a few, or even over a dozen years, after implantation, because it is difficult to predict the risk factors for their occurrence, as well as to establish a single mode of action. The most commonly used method of treatment of such complications is complete removal of the system, i.e. transvenous lead extraction (TLE). The Heart Rhythm Society (HRS) guidelines from 2009 [1] concerning indications for TLE, and their updated version from 2017 [6] , do not solve all the problems related to this field, often recommending the individualisation of therapy, especially in patients without symptoms of infection. It is therefore necessary to conduct further studies to clarify the indications for TLE due to non-infectious causes and clearly define their place in electrotherapy.
METHODS
Retrospective analysis of the clinical data of 225 patients (36% women) hospitalised in the Regional Cardiology Centre in the years 2006 to 2015 due to complications associated with PM/ICD/CRT was conducted. All patients undewent TLE, and all the procedures were performed by an experienced operator in a single Reference Centre. TLE was performed using polypropylene Byrd dilators (Cook ® Medical, Leechburg, PA, USA) or rarely with the use of mechanical catheters (Evolution, Cook; TighRail Spectranetix). In the TLE centre, catheters using laser energy or electrosurgical dissection sheaths were not used. In the study group, 176 (78.2%) patients with non-infectious indications for TLE were identified, and there were 49 (21.8%) patients with infectious complications. Non-infectious indications included various types of lead dysfunction: breaking of the lead, dislocations (loops of the leads), late dry perforations of the exit block type with disorders of pacing, sensing, and resistance (P/S/R), symptomatic venous obstructions as well as the need for elective replacement of Sprint Fidelis leads, and prophylactic extractions of abandoned, redundant leads. Infections related to the presence of PM/ICD/CRT were divided into pocket infection (PI), lead-related infective endocarditis (LRIE), and PI coexisting with LRIE.
The phenomenon of intracardiac abrasion of a lead was defined as macroscopically visible damage of external insulation located only in its intracardiac part, usually in the first 15 to 20 cm from the tip. The presence of abrasion was confirmed on microscopic examinations [7, 8] carried out by researchers from the TLE centre to which study patients were referred.
Concepts such as TLE, total and clinical success of the procedure, major and minor complications, local PI, and LRIE were defined according to the 2017 TLE HRS guidelines [6] and the 2015 European Society of Cardiology guidelines [9] .
In particular groups and subgroups of patients, the potential clinical factors and procedural complications of electrotherapy were evaluated. On the basis of univariate and multivariate analyses, risk factors for infectious complications were identified. The effectiveness of procedures, the occurrence of major and minor complications, and long-term survival after TLE were also assessed.
Survival status and date of death were obtained from the Ministry of Internal Affairs until 2014. In the years 2014 and 2015 these data were complemented by the National Health Fund. The survival observation was completed in all patients after TLE. The authors have an official permit to obtain these data.
The study was approved by the local Bioethics Committee (decision number 02/2012).
Statistical analysis
The examined data are presented for all patients and for subgroups of patients classified according to the type of detected infectious complications. Continuous variables are presented as mean ± standard deviation and were compared using Student t test. Categorical data are presented as absolute numbers and percentages and were compared using the c 2 test with Yates correction. If the p-value was less than 0.05, the odds ratio with 95% confidence interval was calculated. Calculation of Cox proportional hazards regression analysis (uni-and multivariate) was applied to identify the variables associated with infective system dysfunction and prognosis after TLE. Multivariate regression analysis included the data that obtained a p-value of < 0.1 in univariate analysis. Survival analysis based on Kaplan-Meier curves and log-rank tests was used to assess the death-free survival after TLE depending on the type of detected infectious complications. Differences between the groups were considered statistically significant at p < 0.05. If the p-value ranged between 0.05 and 0.1 (estimated to the third decimal place), the value of p ≥ 0.1 was determined as non-statistical. Statistical analysis was performed with 10.0 Statistica software (StatSoft Inc., Tulsa, OK, USA).
RESULTS
The study included 225 patients (36.9% patients with ICD, 3.9% with CRT) in whom a total of 313 leads were removed. Among them, 176 (78.2%) patients were referred for TLE due to non-infectious indications, and 49 (21.8%) patients due to causes related to infection (Fig. 1A) . In patients with infectious complications, the causes for referral for TLE were isolated PI in 16 (32.7%) patients, PI with LRIE in 23 (46.9%) patients, and isolated LRIE in 10 (20.4%) patients (Fig. 1B) .
Non-infective causes for qualification for TLE were divided into classes in accordance with the HRS guidelines [1, 3] . The presented classification distinguishes primary and lower-level indications. The most common type of indication for TLE was the removal of superfluous non-functional leads -it was present in 79.5% of patients and constituted a primary indication in 52.8% of cases. Another indication was the presence of leads that pose a potential threat to the patient, it was identified in 54.5% of patients and classified as a primary indication in 29.5% of them. Among the primary indications, an important one was the need for the removal of an excess of functional leads, demonstrated by 6.3% of patients. A very important indication of the lower-level was the need for the recapture of venous access, identified in 15.9% of patients. Other types of indications included interference with an active pacing system or with anti-cancer therapy, chronic pain at the site of device insertion, receswww.kardiologiapolska.pl Analysis of electrotherapy complications sion of pacing indication, recalled leads, and missed tip location ( Table 1) .
Analysis of clinical factors potentially affecting the development of electrotherapy complications showed a higher incidence of chronic renal failure (CRF) in patients with LRIE. Other clinical parameters were comparable between subjects in different groups and subgroups ( Table 2) .
Comparison of factors related to implantable devices showed more frequent presence of abandoned, non-functional leads in patients with infectious complications (especially in patients with LRIE), including systems implanted on both sides of the chest, and a greater number of implanted leads in this group of patients. In patients referred for TLE due to infection, significantly more previous CIED-related procedures were also observed, with a clearly shorter time interval since the last procedure preceding TLE, and the largest number of early reinterventions in patients with PI. The study showed no significant difference between the type of the implanted system and the dwell time of the leads removed in infectious and non-infectious groups (Table 2) .
Major TLE complications were observed in one (0.4%) patient, and minor complications in three (1.3%) patients. In the studied population no periprocedural death occurred ( Table 2) .
Assessment of the risk for infectious complications
Based on univariate analysis, a higher incidence of infectious complications in patients with CRF was observed, with a greater number of implanted leads (in particular non-functional, abandoned ones), older leads (with a higher sum of the lead dwell time), and more frequent history of prior CIED-related procedures, in particular performed in a shorter span of time before TLE (Table 3) .
Multivariate analysis confirmed the effect of CRF and a greater number of procedures preceding TLE on the development of infectious complications (Table 4) .
Among the parameters potentially affecting the development of isolated pocket infection, based on univariate analysis, the importance of the number of leads and the number of procedures prior to TLE, especially early reinterventions, was highlighted ( Table 5) .
Analysis of factors potentially affecting the development of PI coexisting with LRIE revealed significant effects of CRF, the number of implanted leads, especially non-functional ones, and the number of prior procedures, especially those performed a short time before TLE (Table 6) .
Among the factors potentially affecting the development of isolated LRIE, univariate analysis demonstrated the importance of the number of leads, especially abandoned ones, the impact of lead dwell time (the sum of dwell time of all the leads), and the number of procedures preceding TLE, in particular those performed a short time before TLE ( Table 7) .
Evaluation of the effectiveness
and safety of TLE Total procedural success was observed in 96.9% of patients undergoing TLE, and clinical success was observed in 99.6% of patients. In the whole population there was no periprocedural death. A major complication occurred in one patient -pericardial tamponade controlled by drainage of the pericardium. Minor complications were observed in three (1.3%) patients and included significant tricuspid regurgitation associated with the rupture of the chordae tendineae during TLE (two www.kardiologiapolska.pl Table 1 . Data are shown as number (percentage) or mean ± standard deviation. *p < 0.05; **p < 0.01; ***p < 0.001. CIED -cardiovascular implantable electronic devices; CRT-D -cardiac resynchronisation therapy defibrillator; CRT-P -cardiac resynchronisation therapy pacemaker; CS -coronary sinus; ICD -implantable cardioverter defibrillator; LVEF -left ventricular ejection fraction; NYHA -New York Heart Association; TLE -transvenous leads extraction patients) and air embolism (one patient). The effectiveness of treatment in patients with infectious and non-infectious complications was comparatively high ( Table 1) .
Classification of non-infectious indications for transvenous leads extraction (TLE) according to the Heart Rhythm Society (HRS) guidelines

Indication for TLE
Analysis of survival after TLE Rating long-term survival after TLE (mean follow-up period of 3.0 ± 2.14 years in the whole studied group) showed significantly higher mortality among patients with infectious complications. During a five-year observation period, the mortality rate in this group was about 50%, compared with about 20% in the non-infectious group (p < 0.05; Fig. 2 ).
DISCUSSION
Complications of electrotherapy are a relatively new problem in modern cardiology, and so there are few studies on the methods of action in a variety of clinical situations, while therapeutic standards are based on the short duration of patient observation. In the present study, in the group of patients referred for TLE in the years 2006-2015, a very low percentage of infectious complications (21.9%) representing an absolute indication for TLE was demonstrated. This rate is highly variable depending on the centre and the study population. In most TLE centres the percentage of infectious indications is 40% to 60% [10] [11] [12] , but it may even reach the level of 70% to 80% [13, 14] . In recent years, however, there have been studies showing significantly more frequent referral for TLE due to non-infectious causes. Based on the analysis of data from the National Cardiovascular Data Registry from the period of 2010 to 2012, it was determined that the percentage of infectious indications in this population was only 15% [15] . The existence of such a large discrepancy may be due to steadily increasing awareness of the complications of electrotherapy, which may result in their frequent recognition at an early stage, leading to the prevention of the development of infectious complications. This concept has been confirmed in the current study; the important factors in the risk of infections associated with PM/ICD/CRT were the number of CIED-related procedures preceding TLE, and a greater number of implanted leads, especially superfluous and abandoned ones in patients with LRIE. Such results have been reported in studies based on large populations of patients undergoing TLE [16, 17] .
Detailed analysis of non-infectious complications in the current population showed that the dominant indication for TLE was the presence of unnecessary, abandoned leads (52.8% of primary indications, 79.5% of all indications) and extraction of potentially threatening leads (29.5% and 54.5%, respectively). This type of indication is most often identified as class IIb in the HRS guidelines [6] . In clinical practice this means special consideration of the risk-benefit balance of the procedure. The spectrum of non-infective indications, especially the percentage of extraction of functional and non-functional leads, illustrates how frequently our doctors consider lots of patients with long life perspectives with abandoned leads in terms of problems far in the future.
www.kardiologiapolska.pl Abbreviations -see Tables 2 and 3 www.kardiologiapolska.pl Abbreviations -see Tables 2 and 3 Figure 2. Kaplan-Meier survival curves of patients with complications of electrotherapy. Survival in the whole group of patients after transvenous lead extraction depending on aetiology: p < 0.05
The present study confirmed the high effectiveness and safety of TLE. According to reports evaluating TLE procedures in various populations, the overall procedural success ranged from 91%, in cases where the application of laser energy predominated [18] to 96%-98% in centres that preferred Byrd dilators and mechanical catheters [12, 19, 20] . The rate of major complications in these studies ranged from 0.3% to 3.4% and was higher when laser techniques were used [12, [18] [19] [20] . As stated in the present study, an overall procedural success rate of 96.9%, a clinical success rate of 99.6% with a major complication rate of 0.4%, and the absence of periprocedural deaths support the very high effectiveness and safety of TLE procedures in a population with predominantly non-infectious indications.
The present study also confirmed, similarly to other studies, a relatively high (30%-50%) long-term mortality in the population of patients undergoing TLE. The factors most frequently identified as increasing mortality in long-term follow-up are age, diabetes, renal insufficiency, and infectious complications [13, [21] [22] [23] . In most reports, beneficial direct effects of TLE procedures are emphasised, especially in patients referred for the procedure due to infection, although the long-term survival of this population is low [24, 25] . The www.kardiologiapolska.pl Analysis of electrotherapy complications present study confirmed a significantly higher five-year mortality among patients with infectious complications. This observation may also result from the more unfavourable clinical profile of this group, not only from the presence of infection.
The main limitation of the study is the small study population, the lack of a thorough follow-up of patients after TLE procedures, and especially the lack of data on the direct cause of death in the long-term follow-up and its relationship to infectious complications.
In conclusion, a 10-year analysis of long-term complications associated with the presence of PM/ICD/CRT showed that thorough diagnosis and effective treatment of non-infectious adverse events may prevent the development of the most dangerous infectious complications. In the present study, confirmed high effectiveness and safety of procedures performed in an experienced centre should prompt an early, preventive referral for TLE. Such action is very important in light of the high long-term mortality among patients with infectious complications.
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